1-8 of 8
Michelle Limei Poon
Close
Sort by
Journal Articles

Co-Expression of C-MYC/BCL2 Is Associated with Inferior Survival Outcomes in Relapsed/Refractory Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation - a Nationwide Retrospective Analysis in Singapore

Jing Yuan Tan, Victor Ling Wei Teik, Cindy Krisnadi, Lawrence Cheng Kiat Ng, Melinda Si Yun Tan, Nicholas Francis Grigoropoulos, Shin Yeu Ong, Chandramouli Nagarajan, Jeffrey Kim Siang Quek, Hein Than, Joanne Shu Xian Lee, Esther Hian Li Chan, Lip Kun Tan, William Ying Khee Hwang, Yeow Tee Goh, Yeh Ching Linn, Liang Piu Koh, Aloysius Yew Leng Ho, Francesca Lorraine Wei Inng Lim, Michelle Limei Poon, Yunxin Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 3601.
https://doi.org/10.1182/blood-2023-184423
Published: 2023
Journal Articles

Odronextamab in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2

Won-Seog Kim, Tae Min Kim, Seok-Goo Cho, Isidro Jarque, Elżbieta Iskierka-Jażdżewska, Michelle Limei Poon, H. Miles Prince, Sung Yong Oh, Francesca Lim, Cecilia Carpio, Tran-Der Tan, Sabarish Ayyappan, Antonio Gutierrez, Jingjin Li, Melanie Ufkin, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth R. Ambati, Jan Walewski
Journal: Blood
Blood (2022) 140 (Supplement 1): 1070–1071.
https://doi.org/10.1182/blood-2022-158406
Published: 2022
Journal Articles

Odronextamab in Patients with Relapsed/Refractory (R/R) Follicular Lymphoma (FL) Grade 1-3a: Results from a Prespecified Analysis of the Pivotal Phase II Study ELM-2

Tae Min Kim, Michal Taszner, Seok-Goo Cho, Silvana Novelli, Steven Le Gouill, Michelle Limei Poon, Jose C. Villasboas, Rebecca Champion, Emmanuel Bachy, Stéphanie Guidez, Aránzazu Alonso Alonso, Deepa Jagadeesh, Michele Merli, David Tucker, Jingxian Cai, Carolina Leite De Oliveira, Min Zhu, Aafia Chaudhry, Hesham Mohamed, Srikanth R. Ambati, Stefano Luminari
Journal: Blood
Blood (2022) 140 (Supplement 1): 2280–2282.
https://doi.org/10.1182/blood-2022-158404
Published: 2022
Journal Articles

Epcoritamab Monotherapy Provides Deep and Durable Responses Including Minimal Residual Disease (MRD) Negativity: Novel Subgroup Analyses in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Tycel Phillips, Catherine Thieblemont, Herve Ghesquieres, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana A. Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Nurgul Kilavuz, Mariana Cota Stirner, David Soong, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliot, Martin Hutchings, Pieternella Lugtenburg
Journal: Blood
Blood (2022) 140 (Supplement 1): 9443–9445.
https://doi.org/10.1182/blood-2022-158245
Published: 2022
Journal Articles

Haploidentical Transplant Using Selective Ex-Vivo Tcrαβ Depleting and Memory T Cell Add-Back Results in More Favorable Gvhd-Free /Relapse Free Survival (GRFS) As Compared to Post-Transplant Cyclophosphamide for Adults with Hematological Malignancies - a Comparative Analysis of 170 Patients in a Multicenter Study in Singapore

Victor Ling Wei Teik, Yeh Ching Linn, Michelle Limei Poon, Jeffrey Quek, Lip Kun Tan, Zi Yi Lim, Colin Phipps Diong, Balamurugan Vellayappan, Joanne Lee, William YK Hwang, Hein Than, Aloysius YL Ho, Ian Wu, Yang Liang Boo, Teck Guan Soh, Gina Gan, Yvonne Su Ming Loh, Yin Jie Koh, Liang Piu Koh
Journal: Blood
Blood (2022) 140 (Supplement 1): 10500–10501.
https://doi.org/10.1182/blood-2022-168851
Published: 2022
Journal Articles

Sequential Use of Flamsa, FLAG, CLAG or TEC-Based Conditioning Regimen Followed By Allogeneic Hematopoietic Transplantation Results in Favorable Outcome for High Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasia Patients: 15 Year Follow-up of the Multicenter Study in Singapore

Lip Leong Chong, Yang Liang Boo, Yin Jie Koh, Joanne Lee, Michelle Limei Poon, Jeffrey Quek, Hein Than, Yeh Ching Linn, William YK Hwang, Aloysius YL Ho, Lip Kun Tan, Liang Piu Koh
Journal: Blood
Blood (2022) 140 (Supplement 1): 7605–7606.
https://doi.org/10.1182/blood-2022-164524
Published: 2022
Journal Articles

A Non-Coding Variant in LOC105371512 Confers Susceptibility to Bleomycin-Induced Lung Injury

Joanne Lee, Hossein Tabatabaeian, Michelle Limei Poon, Nagavalli Somasundaram, Liu Xin, Yi Ching Yuen, Chia Meng Teoh, Benedict Yan, Esther Hian Li Chan, Yen Lin Chee, Sanjay De Mel, Bin Zhang, Xiao Hong Chew, Tiffany Tang, Chiea Chuen Khor, Joanne Yuen Yie Ngeow, Choon Kiat Ong, Soon Thye Lim, Wee Joo Chng, E Shyong Tai, Kee Yuan Ngiam, Soo Chin Lee, Boon Cher Goh, Anand Devaprasath D. Jeyasekharan, Yvonne Tay, Folefac Aminkeng
Journal: Blood
Blood (2022) 140 (Supplement 1): 4542–4544.
https://doi.org/10.1182/blood-2022-169416
Published: 2022
Journal Articles

Haploidentical Hematopoietic Cell Transplantation of Ex Vivo Tcrαβ-Depleted Grafts with CD45RA-Depleted Memory T Cell Add-Back Reduces Chronic Graft-Versus-Host Disease and Results in Favourable Gvhd-Relapse Free Survival: 5-Year Follow-up of 107 Patients Treated in a Multicenter Study in Singapore

Liang Piu Koh, Michelle Limei Poon, Jeffrey Quek, Lip Kun Tan, Rajat Bhattacharyya, Michaela Su-Fern Seng, Zi Yi Lim, Poh Lin Tan, Colin Phipps Diong, Balamurugan Vellayappan, Ah Moy Tan, Joanne Lee, William Y.K. Hwang, Hein Than, Aloysius Ho, Ian Q.H. Wu, Yang Liang Boo, Yvonne S.M. Loh, Teck Guan Soh, Gina Gan, Kheng Wei Yeoh, Wen Shen Looi, Bryan S.H. Ho, Yin Jie Koh, Wing Y. Leung, Yeh Ching Linn
Journal: Blood
Blood (2022) 140 (Supplement 1): 4707–4708.
https://doi.org/10.1182/blood-2022-168995
Published: 2022